Lavizzari, Anna http://orcid.org/0000-0001-5529-0787
Veneroni, Chiara
Beretta, Francesco
Ottaviani, Valeria
Fumagalli, Claudia
Tossici, Marta
Colnaghi, Mariarosa
Mosca, Fabio
Dellacà, Raffaele L.
Article History
Received: 2 September 2021
Accepted: 25 November 2021
First Online: 20 December 2021
Declarations
:
: The study protocol obtained the ethical committee approval (Milano Area 2; protocol no. 462_2015) in April 2016. The parents of all patients enrolled signed the consent for participation before the study entry.
: Not applicable.
: RD reports Grants and others from Restech, personal fees from Philips Healthcare, outside the submitted work; Dr. Dellaca’ has a patent on the detection of EFL by Forced Oscillation technique (FOT) with royalties paid to Philips Respironics and Restech Srl, a patent on monitoring lung volume recruitment by FOT with royalties paid to Vyaire, and a patent on early detection of exacerbations by home monitoring of FOT with royalties paid to Restech and is co-founder and shareholder of Restech Srl, a spin-off company of the Politecnico di Milano University producing medical devices for lung function testing based on FOT. AL was a consultant for Getinge, Vyaire and Chiesi S.p.A and received travel grants from Vapotherm and Fischer&Pykel. The other authors have no financial interest to declare.